# Diatos

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/diatos

- Industry: Biotechnology
- Headquarters: Paris, France
- Total disclosed funding: $13M
- Latest round: Series D (Jul 3, 2007)
- Investors on record: 9

## About

Diatos S.A. is a biopharmaceutical company, focuses on the research, development, and commercialization of targeted anti-cancer drugs.

## Funding rounds

- Series D, Jul 3, 2007, $13M — InterWest Partners, Sofinnova Partners, Idinvest Partners, SGAM Private Equity, Gimv, Daiwa Corporate Investment, Omnes Capital, IPSA, Vives

## Investors

- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series D
- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series D
- Idinvest Partners (https://capitalatlas.ai/funds/idinvest-partners) — Series D
- SGAM Private Equity (https://capitalatlas.ai/funds/sgam-private-equity) — Series D
- Gimv (https://capitalatlas.ai/funds/gimv) — Series D
- Daiwa Corporate Investment (https://capitalatlas.ai/funds/daiwa-corporate-investment) — Series D
- Omnes Capital (https://capitalatlas.ai/funds/omnes-capital) — Series D
- IPSA (https://capitalatlas.ai/funds/ipsa) — Series D
- Vives (https://capitalatlas.ai/funds/vives) — Series D